Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells

Anaerobe

Volumn 28, Issue , 2014, Pages 29-36

  Nami, Yousef ^a   Abdullah, Norhafizah ^a   Haghshenas, Babak ^a   Radiah, Dayang ^a   Rosli, Rozita ^a   Khosroushahi, Ahmad Yari ^b,c  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti microbe; Antibiotic susceptibility; Anticancer; Apoptosis; Cytotoxicity

Indexed keywords

ACID; AMPICILLIN; BILE SALT; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; NUTRACEUTICAL; PACLITAXEL; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; SULFAMETHOXAZOLE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; CARBOXYLIC ACID; RIBOSOME DNA; RNA 16S;

16S RDNA GENE; ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; CANCER CELL; CELL ASSAY; CELL STRAIN AGS; CELL STRAIN HELA; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG ISOLATION; ETHNIC GROUP; FEMALE; FEMALE FERTILITY; FLOW CYTOMETRY; GENE SEQUENCE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IRAN; IRANIAN; LACTOBACILLUS ACIDOPHILUS; MCF 7 CELL LINE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; VAGINA FLORA; ANTIBIOSIS; BILE; CELL SURVIVAL; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VAGINA; YOUNG ADULT;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOSIS; APOPTOSIS; BACTERIAL TYPING TECHNIQUES; BILE; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CELL SURVIVAL; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; HUMANS; LACTOBACILLUS ACIDOPHILUS; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; VAGINA; YOUNG ADULT;

EID: 84901411739     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.04.012     Document Type: Article

References (68)

1. Guarner F., Perdigon G., Corthier G., Salminen S., Koletzko B., Morelli L. Should yoghurt cultures be considered probiotic?. Br J Nutr 2005, 93:783-786.
2. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 360:512-519.
3. Shanahan F. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br J Nutr 2002, 88:5-9.
4. Alvarez-Olmos M.I., Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001, 32:1567-1576.
5. Jacobsen C.N., Nielsen V.R., Hayford A.E., Moller P.L., Michaelsen K.F., Paerregaard A. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by invitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999, 65:4949-4956.
6. Gorbach S.L. The discovery of Lactobacillus GG. Nutrition 1996, 31:2-4.
7. Greene J.D., Klaenhammer T.R. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol 1994, 60:4487-4494.
8. Kirjavainen P.V., Ouwehand A.C., Isolauri E., Salminen S.J. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998, 167:185-189.
9. Miranda C.L., Stevens J.F., Hemlmrich A., Henderson M.C., Rodriguez R.J., Yang Y.H., et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Human lupulus) in human cancer cell lines. Food Chem Toxicol 1999, 37:271-285.
10. Hsu Y.L., Kuo P.L., Lin L.T., Lin C.C. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. JPharmacol Exp Ther 2005, 313:333-344.
11. Li Y., Ahmed F., Ali S., Philip P.A., Kucuk O., Sarkar F.H. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agent in human cancer cells. Cancer Res 2005, 65:6934-6942.
12. Rahmati M., Bannazadeh H., Fazli D., Tahmasebzadeh F., Farrokhi A., Rasmi Y. The apoptotic and cytotoxic effects of Polygonum avicular extract on HeLa-S cervical cancer cell line. Afr J Biochem Res 2011, 5:373-378.
13. Dartsch D.C., Schaefer A., Boldt S., Kolch W., Marquardt H. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis 2002, 7:537-548.
14. Sneath P.A., Mair N.S., Sharpe M.E., Hoh J.G. Bergey's manual systematic bacteriology 1986, 1208-1235. Williams and Wilkins, Baltimore. 9th ed.
15. Cardinal M.J., Meghrous J., Lacroix C., Simard R.E. Isolation of Lactococcus lactis strain producing inhibitory activity against Listeria. Food Biotechnol 1997, 11.
16. Lane D.J., Pace B., Olsen G.J., Stahlt D.A., Sogint M.L., Pace N. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci U S A 1986, 82:6955-6959.
17. Dubernet S., Desmasures N., Gueguen M. APCR-based method for identification of lactobacilli at the genus level. FEMS Microbiol Lett 2002, 214:271-275.
18. Endo A., Okada S. Monitoring the lactic acid bacterial diversity during shochu fermentation by PCR-denaturing gradient gel electrophoresis. JBiosci Bioeng 2005, 3:216-221.
19. Claire L., Glenn V., Gibson R., Robert A. Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium. JAppl Microbiol 2006, 100:846-853.
20. Dimitonova S.P., Danova S.T., Serkedjieva J.P., Bakalov B.V. Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 2007, 13:178-184.
21. Maldonado N.C., De Ruiz C.S., Otero M.C., Sesma F., Nader-Macías M.E. Lactic acid bacteria isolated from young calves - characterization and potential as probiotics. Res Vet Sci 2012, 92:342-349.
22. Nowroozi J., Mirzaii M., Norouzi M. Study of Lactobacillus as probiotic bacteria. Iran J Publ Health 2004, 33:1-7.
23. Galvez A.A., Dubois-Dauphin R., Ghalfi H., Campos D., Thonart P. Description of two Enterococcus strains isolated from traditional Peruvian artisanal-produced cheeses with a bacteriocin-like inhibitory activity. Biotechnol Agron Soc Environ 2009, 13:349-356.
24. Barzegari A., Saei A.A. Designing probiotics with respect to the native microbiome. Future Microbiol 2012, 7:571-575.
25. Fernandez M.F., Boris S., Barbes C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. JAppl Microbiol 2003, 94:449-455.
26. Merghoub N., Benbacer L., Amzazi S., Morjani H., El Mzibri M. Cytotoxic effect of some Moroccan medicinal plant extracts on human cervical cell lines. JMed Plants Res 2009, 3:1025-1050.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. JImmunol Methods 1983, 16:55-63.
28. Paolillo R., Romano Carratelli C., Sorrentino S., Mazzola N., Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol 2009, 9:1265-1271.
29. Westermann B. Molecular machinery of mitochondrial fusion and fission. JBiol Chem 2008, 283:13501-13505.
30. Zavisic G., Radulovic Z., Vranic V., Begovic J., Topisirovic L., Strahinic I. Characterization and antimicrobial activity of vaginal Lactobacillus isolate. Arch Biol Sci Belgr 2011, 63:29-35.
31. Todorov S.D., Botes M., Danova S.T., Dicks L.M. Probiotic properties of Lactococcus lactis ssp. lactis HV219, isolated from human vaginal secretions. JAppl Microbiol 2007, 103:629-639.
32. Prinsloo S., Pieters R., Bezuidenhout C.C. Acell viability assay to determine the cytotoxic effects of water contaminated by microbes. SAfr J Sci 2013, 109:1-4.
33. Collins J.K., Thornton G., Sullivan G.O. Selection of probiotic strains for human applications. Int Dairy J 1998, 8:487-490.
34. Lee J., Yun H.S., Cho K.W., Oh S., Kim S.H., Chun T., et al. Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: immune modulation and longevity. Int J Food Microbiol 2011, 148:80-86.
35. Chou L.S., Weimer B. Isolation and characterization of acid and bile tolerant isolates from strains of Lactobacillus acidophilus. JDairy Sci 1999, 82:23-31.
36. Pan X., Chen F., Wu T., Tang H., Zhao Z. The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Control 2009, 20:598-602.
37. Zhang Y., Zhang L., Ma W., Yi H.X., Yang X., Du M., et al. Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe 2012, 1-6.
38. Zhang Y., Zhang L., Dua M., Yi H., Guoa C., Tuo Y., et al. Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food. Microbiol Res 2011, 167:27-31.
39. Charteris W.P., Kelly P.M., Morelli L., Collins J.K. Development of an invitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. JAppl Microbiol 1998, 84:759-768.
40. Saarela M., Mogensen G., Fonden R., Matto J., Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties. JBiotechnol 2000, 84:197-215.
41. Salminen S., Von Wright A., Morelli L., Marteau P., Brassart D., Vos De W.M., et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998, 44:93-106.
42. Zhou J.S., Pillidge C.J., Gopal P.K., Gill H.S. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int J Food Microbiol 2005, 98:211-217.
43. Argyri A.A., Zoumpopoulou G., Karatzas K.A., Tsakalidou E., Nychas G.-J.E., Panagou E.Z., et al. Selection of potential probiotic lactic acid bacteria from fermented olives by invitro tests. Food Microbiol 2013, 33:282-291.
44. Woodford N., Johnson A.P., Morrison D., Speller D.C.E. Current perspective on glycopeptide resistance. Clin Microbiol Rev 1995, 8:585-615.
45. Johnson A.P., Uttley A.H.C., Woodford N., George R.C. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990, 3:280-291.
46. Klein G., Pack A., Bonaparte C., Reuter G. Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998, 41:103-105.
47. Handwerger S., Pucci M.J., Volk K.J., Liu J.P., Lee M.S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. JBacteriol 1994, 176:260-264.
48. Jamalifar H., Rahimi H., Samadi N., Shahverdi A., Sharifian Z., Hosseini F., et al. Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol 2011, 3:21-25.
49. Tynkkynen S., Singh K.V., Varmanen P. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 1998, 41:195-204.
50. Choi S.Y., Chang C.E., Kim S.C., So J.-S. Antimicrobial susceptibility and strain prevalence of Korean vaginal Lactobacillus spp. Anaerobe 2003, 9:277-280.
51. Lee H., Yoon H., Ji Y., Kim H., Park H., Lee J., et al. Functional properties of Lactobacillus strains isolated from kimchi. Int J Food Microbiol 2011, 145:155-161.
52. Olukoya D.K., Ebigwi S.I., Adebawo O.O., Osiyemi F.O. Plasmid profiles and antibiotic susceptibility patterns of Lactobacillus isolated from fermented foods in Nigeria. Food Microbiol 1993, 10:279-285.
53. Thirabunyanon M., Hongwittayakorn P. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol 2013, 169:511-525.
54. Motevaseli E., Shirzad M., Akrami S.M., Mousavi A.S., Mirsalehian A., Modarressi-Hossein M. Normal and tumor cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. JMed Microbiol 2013, 62:1065-1072.
55. Rafter J. the effects of probiotic on colon cancer development. Nutr Rev 2004, 17:277-284.
56. Hirayama K., Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect 2000, 2:671-686.
57. Lee J.W., Shin J.G., Kim E.H., Kang H.E., Yim I.B., Kim J.Y., et al. Immunomodulatory and antitumor effects invivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. JVet Sci 2004, 5:41-48.
58. Pessi T., Sutas Y., Saxelin M., Kallioinen H., Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 1999, 65:4725-4728.
59. Ewaschuk J.B., Walker J.W., Diaz H., Madsen K.L. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs invitro and invivo in mice. Nutrition 2006, 136:1483-1487.
60. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer 1972, 68:239-257.
61. Wyllie A., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306.
62. Gonzalez-Marin C., Gosalvez J., Roy R. Types, causes, detection and repair of DNA fragmentation in animal and human sperm cells. Int J Mol Sci 2012, 13:14026-14052.
63. Matalova E., Spanova A. Detection of apoptotic DNA ladder in pig leukocytes and its precision using LM-PCR (ligation mediated polymerase chain reaction). Acta Vet Brno 2002, 71:163-168.
64. Saraste A. Morphologic criteria and detection of apoptosis. Herz 1999, 24:189-195.
65. Enari M., Sakahira H., Yokoyama H. Acaspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391:43-50.
66. Collins R.J., Harmon B.K., Gobe G.C., Kerr J.F.R. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 1992, 61:451-453.
67. Anderson H.A., Englert R., Gursel I., Shacter E. Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. Cell Death Differ 2002, 9:616-625.
68. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells invitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. JClin Invest 1998, 101:890-899.